Open Nav

Below are just a few of the investment firms already registered at the 2016 BIO CEO & Investor Conference. More than 200 investors have registered as of 1/7/2016.  To apply for complimentary investor registration, please click here.

To view the list of participating companies, please click here.


Adamas Healthcare Fund
Advent Capital Management
American Century Investments
Anson Group Canada
Archer Avenue Partners
Arcus Ventures
Asahi Kasei America
Ashford Capital Management
Aspire Capital
ATEL Ventures
ATEM Capital
Athyrium Capital Management
BDC Capital Healthcare Fund
Biomed Ventures
Brookside Capital/Bain Capital
Burrage Capital
Calamos Investments
Cedrus Investments
Daniloff Capital
Deerfield Management 
Easton Capital
EGB Advisors
Enso Ventures
E Squared Capital
Federated Kaufman Fund
Five Corners Capital
Foresite Capital Management
Fountain Healthcare Partners
H.I.G. Bioventures
Hercules Technology Growth Capital
JMJ Financial 
Jump Capital
Juvenile Diabetes Research Foundation (JDRF)
Knoll Capital Management
Kodiak Capital Group 
Lincoln Park Capital
Longitude Capital
Marathon Asset Management
Merlin Nexus
Mount Sinai Fund
MPM Capital/Science Seed
Muse Capital
New Enterprise Associates
NJ Investment Division
NYS Innovation VC Fund
Oxford Finance
Pappas Ventures
Pipeline Capital
Point 72 Partners
RA Capital
Ridgeback Capital Management
Sabby Management
Sarissa Capital Management
Seaview LLC
Sector Asset Management
Slater Technology Fund
Sofinnova Ventures 
Special Situations Life Sciences Fund
Symphony Capital
The Lind Partners
V2M Capital
Versant Ventures
Weiss Multi Strategy Advisers
Wexford Capital


Research Analysts:

Bank of America/Merrill Lynch
Brean Capital
Cantor Fitzgerald
Chardan Capital Markets
FBR & Co.
Griffin Securities
H.C. Wainwright
Ladenburg Thalmann
Laidlaw & Company
Lifetech Capital
Maxim Group
Morgan Stanley
Needham & Co.
Noble Life Sciences
Piper Jaffray
RBC Capital Markets
ROTH Capital Partners
Source Capital
Sun Trust Humphrey Robinson


As of 1/14/2016